Study Links Early Statin Use After Diabetes Diagnosis to Lower Dementia Risk

<p>Starting statin therapy shortly after a type 2 diabetes diagnosis may protect the heart and is linked to a lower dementia risk, according to a study presented at the European Society of Cardiology Congress in Munich on August 30. The study found that adults who began taking a statin within one year of their type 2 diabetes diagnosis had a 15% lower relative risk of developing dementia over 10 years compared to those who did not take the medication within five years.</p><p>For those who delayed starting a statin for one to five years, there was still a 10% lower relative risk, as reported in The Lancet Regional Health – Europe. Researchers tracked health data from 132,585 patients in Denmark diagnosed with type 2 diabetes between 2006 and 2019, who had no prior history of statin use or dementia.</p><p>During a median follow-up of 7.1 years, the team analyzed how the timing of statin treatment impacted overall dementia rates. Dr. Liron Sinvani, a geriatrician and director for research and innovation at the Northwell Institute for Healthy Aging in New York, described the study as a "well-designed, large-scale observational study that adds to a growing body of evidence suggesting that statins may help protect brain health."</p><p>She noted that while a 15% reduction is a modest improvement, it remains "very significant." People with type 2 diabetes have an increased risk of cognitive decline and heart disease, consistent with previous research. Although guidelines generally recommend statins for many adults ages 40 to 75 with diabetes, treatment is not always started soon after a diagnosis.</p><p>The study examined whether the timing of treatment was linked to dementia risk, finding that those who started statins within a year of their diagnosis had a lower risk than those who did not begin treatment. Sinvani emphasized that waiting to start treatment may not be advisable, supporting earlier consideration of statin therapy in routine diabetes care.</p><p>She found the results "especially compelling" because the benefit was driven by a lower risk of vascular dementia rather than Alzheimer's disease. Sinvani explained that this makes biological sense, as statins lower cholesterol, reduce inflammation, and protect blood vessels, which can prevent vascular damage to the brain.</p><p>Statin therapy should be viewed as part of a broader health strategy that includes regular exercise, a healthy diet, and social connections. According to the Lancet Commission, almost half of dementia cases may be preventable or delayable by addressing modifiable risk factors.</p><p>The study had limitations, as it was observational rather than a randomized clinical trial, meaning researchers could not definitively state that statins directly prevent dementia. Sinvani cautioned, "This is not proof that statins prevent dementia, but I think it's an important step in this literature." She encouraged individuals with type 2 diabetes who are not taking a statin to consult their doctor about the appropriateness of the medication.</p>